ProtextP Profile Banner
Protext Pharma Profile
Protext Pharma

@ProtextP

Followers
2K
Following
293
Media
25
Statuses
235

$TXTM is a #Biotech Co. developing a #cannabis medicines platform for legal #cannabisindustry, using proprietary live plant extraction processes & technologies.

Boca Raton, FL
Joined September 2021
Don't wanna be here? Send us removal request.
@ProtextP
Protext Pharma
13 days
Forward-Looking Statements This release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially. The Company undertakes no obligation to update such statements except as required by
1
4
27
@ProtextP
Protext Pharma
13 days
May Your Homes be Filled With Warmth, Your Hearts With Gratitude & Your Path Forward with Opportunity & Abundance. Thank You for Being Part of the $TXTM journey. The future we are building is stronger & brighter because of you. With respect & appreciation, The TXTM Team
1
6
42
@ProtextP
Protext Pharma
13 days
This Season Reminds Us of Unity, Generosity, Hope, and RAOK (Random Acts of Kindness) Values Deeply Aligned With Our mission to build technology and operational frameworks that serve people, empower communities, and create long-term value.
1
4
27
@ProtextP
Protext Pharma
13 days
9. A Message to Our Shareholders To Our global #TXTMTribe🌍 As the Year Closes & the Spirit of the season fills the air, We Express sincere Gratitude to Each of You. Your Trust, Belief & Continued Support are the Foundation Upon Which TXTM grows & Moves Forward with Purpose.
5
6
41
@ProtextP
Protext Pharma
13 days
We have positioned the Company to navigate structural change from a position of strength rather than speculation. This is about execution, stewardship, and shared outcomes.”
1
3
36
@ProtextP
Protext Pharma
13 days
8. CEO Statement. $TXTM is not preparing for the future — we are already operating within it and helping lead its responsible application. With a zero-debt balance sheet, aligned leadership, and operational assets in place.
2
5
40
@ProtextP
Protext Pharma
13 days
•Global expansion initiatives and strategic partnerships •Continued exploration of compliant technology-driven and RWA frameworks All opportunities are evaluated with discipline, compliance, and long-term value creation as guiding principles.
1
4
35
@ProtextP
Protext Pharma
13 days
7. Strategic Optionality Looking ahead to 2026, TXTM continues to evaluate multiple strategic pathways •Potential uplisting preparation (subject to regulatory review) •Mergers, acquisitions, and joint ventures aligned with shareholder interests
1
4
35
@ProtextP
Protext Pharma
13 days
This is not a pitch deck. It is a business built on execution.
1
4
31
@ProtextP
Protext Pharma
13 days
Global markets are undergoing structural transformation tokenization, RWAs, FX normalization & digitized value TXTM’s architecture is already aligned & in some respects, leading the responsible adoption of these changes.
1
3
32
@ProtextP
Protext Pharma
13 days
6. Operating Ahead of Structural Change TXTM’s strategy is not aspirational — it is already operational.
1
3
30
@ProtextP
Protext Pharma
13 days
•Expansion of the Advisory Board, including the Ambassador of Chad •Continued development of botanical, API, and partnership-driven initiatives
1
3
31
@ProtextP
Protext Pharma
13 days
5. Operational Improvements & Advisory Expansion. Key 2025 operational milestones include. •Launch of a modernized Investor Relations Suite •Internal system upgrades supporting audits, reporting, and disclosure.
1
3
29
@ProtextP
Protext Pharma
13 days
Such FX impacts are standard in multinational operations e.g., IBM) and not speculative.
1
4
29
@ProtextP
Protext Pharma
13 days
Tokenization initiatives reference existing, audit-ready assets. FX tailwind: seed inventory initially recorded at 18.94 ZAR/USD now reflects ~16.95 ZAR/USD, supporting translational benefits in future reporting cycles
1
3
34
@ProtextP
Protext Pharma
13 days
•APIs represent real-world assets (RWAs) grounded in physical inventory. •Comparable RWAs such as commodities (e.g., copper), recently at historic highs, or carbon credits, coal, water etc illustrate how tangible assets can anchor value.
1
3
29
@ProtextP
Protext Pharma
13 days
4. Operational Innovation, APIs, RWAs & FX Context TXTM leverages kettle technology and nanotechnology expertise to convert seed inventory into active pharmaceutical ingredients (APIs), creating tangible, monetizable outputs.
1
3
29
@ProtextP
Protext Pharma
13 days
Upfront contributions including sample products, inventory allocations & infrastructure support IFRS treatment recognizing these contributions as gains, strengthening net results & balance-sheet position Integration into TXTM’s broader operational & monetization framework
1
3
27
@ProtextP
Protext Pharma
13 days
3. Strategic TruLeaf LOI Support & Value Add TXTM acknowledges the strategic support received under the TruLeaf Letter of Intent (LOI): •Non-binding contributions supporting operational readiness and early-stage commercial development.
1
3
27
@ProtextP
Protext Pharma
13 days
This combination of executive alignment, intellectual capital, and operational experience creates a foundation for sustainable value that goes well beyond traditional financial measures.
1
3
26